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In an attempt to assess the structural requirements of hexahydro-sila-difenidol for potency and selectivity, a series 
of analogues modified in the amino group and the phenyl ring were investigated for their affinity to muscarinic M1-
(rabbit vas deferens), Mr (guinea-pig atria) and Mr (guinea-pig ileum) receptors. All compounds were competitive 
antagonists in the three tissues. Their affinities to the three muscarinic receptor subtypes differed by more than two 
orders of magnitude and the observed receptor selectivities were not associated with high affinity. The pyrrolidino and 
hexamethyleneimino analogues, compounds substituted in the phenylring with a methoxy group or a chlorine atom as 
weil as p-fluoro-hexahydro-difenidol displayed the same affinity profile as the parent compound, hexahydro-sila-difen-
idol: M1 = M3 > M 2 • A different selectivity patternwas observed for p-fluoro-hexahydro-sila-difenidol: M3 > M1 > 
M2 • This compound exhibited its highest affinity for M3-receptors in guinea-pig ileum (pA 2 = 7.84), intermediate 
affinity for M1-receptors in rabbit vas deferens (pA 2 = 6.68) and lowest affinity for the Mrreceptors in guinea-pig 
atria (pA 2 = 6.01). This receptor selectivity profile of p-fluoro-hexahydro-sila-difenidol was confirmed in ganglia (M1), 
atria (M 2 ) and ileum (M 3 ) of the rat. Furthermore, dose ratios obtained with either pirenzepine (Mt) or hexahydro-
sila-difenidol (M 2 and M3) and the p-fluoro analogue used in combination suggested that the antagonism was 
additive, implying mutual competition with a single population of muscarinic receptor subtypes. These results indicate 
that p-fluoro-hexahydro-sila-difenidol represents a valuable tool for characterization of muscarinic receptor subtypes. 
Muscarinic receptor subtypes; Muscarinic Mrselective antagonists; Hexahydro-sila-difenidoJ analogues; 
p-Fluoro-hexahydro-sila-difenidol; Pirenzepine; Methoctramine; Vas deferens (rabbit); Ganglia (rat); 
(Structure-activity relationships) 
1. lntroduction 
Radioligand binding and functional data, have 
allowed the clear demonstration that there are at 
least three major subtypes of muscarinic recep-
• To whorn all correspondence should be addressed: Depart-
rnent of Pharrnacology, University of Frankfurt, Theodor-
Stern-Kai 7, Gebäude 75A, D-6000 FrankfurtjM, F.R.G. 
tors: M 1 (neuronal type), M 2 (cardiac type; M 2a, 
Mutschier et al., 1988) and M 3 (smooth muscle/ 
glandular type; M2ß~ Mutschier et al., 1988) (for 
recent reviews, see Birdsall and Hulme, 1983; 
Eglen and Whiting, 1986; Mitchelson, 1988; 
Mutschier et al., 1988). M 1-receptors are found in 
high density in neuronal tissues such as autonotnie 
ganglia, cerebral cortex. and hippocampus, whereas 
M 2- and M 3-receptors are mainly present in lower 
brain areas and in peripheral effector organs such 
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as heart (M 2 ), smooth muscle (M 3 ) and glands 
(M3 ). This pharmacological subclassification of 
musearlnie receptors is based mainly on the differ-
ent affinities of selective antagonists such as 
pirenzepine (M1 > M 2 == M 3) (Hammer et al., 
1980; Hammer and Giachetti, 1982; Doods et al., 
1987; Lambrecht et al., 1988c; Waelbroeck et al., 
1986; 1988), methoctramine and AF-DX 116 (M 2 
> M1 > M3 ) (Melchiorre et al., 1987; Micheletti 
et al., 1987; Melchiorre, 1988; Waelbroeck et al., 
1988), and hexahydro-sila-difenidol (M1 == M3 > 
M2 ) (Fuder et al., 1985; Giraldo et al., 1988; 
Lambrecht et al., 1988a; Waelbroeck et al., 1988). 
More recently, differences in the amino acid 
sequences of musearlnie receptor subtypes have 
been demonstrated by cloning, sequencing and 
expression of complementary DNA encoding these 
receptors (Kerlavage et al., 1987; Peraha et al., 
1987; Akiba et al., 1988; Brann et al., 1988). The 
antagonist binding properlies of the individual 
cloned receptors (ml, m2 and m3) and their pat-
tems of expression in various tissues correspond 
closely to those of the pharmacologically defined 
M1-, M2- and M 3-receptors, respectively (Peralta 
et al., 1987; Akiba et al., 1988; Buckley et al., 
1989). 
Hexahydro-sila-difenidol (!, fig. 2) was dis-
covered in the course of structure-activity (selec-
tivity) relationship studies of a series of difenidol 
and sila-difenidol analogues (fig. 1) (for recent 
reviews, see Tacke and Becker, 1987; Mutschier et 
al., 1988). Structurally, these molecules consist of 
a central carbinol (silanol) carbon (silicon) atom 
carrying an OH group, two ring systems and an 
aminoalkyl group [(CH 2 ) 0 -NR 2 ] (figs. 1 and 2). It 
was found in preceding investigations that the 
potency and selectivity of the difenidol and sila-
9 
HO--El-(CH2) -ND I n 
R 
Fig. 1. General formula of antimuscarinic agents of the difen-
idol (EI = C, R = phenyl, n = 3) and sila:-difenidol (EI =Si, 
R = phenyl, n == 3) type. EI= C, Si; R = aryl. cycloalkyl; n = 
1-4. 
No. NR2 
tX NJ 
z NJ 
' 
N0 
XHaxahydro-slla-difenldol 
No. EI R 
§ Si o-OCH3 
.!i Si p-CI 
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Fig. 2. Chemical structure of hexahydro-sila-difenidol (!) and 
its analogues ~-~. ~ and 7b. 
difenidol analogues are controlled by the nature of 
the central atom (EI= C, Si) and the structure of 
the ring system 'R' bound to this atom, the ab-
solute configuration at the central atom and the 
length of the alkylene chain (Tacke et al., 1986; 
1987; 1989; Eltze et al., 1988; Lambrecht et al., 
1988b; 1989). The main goal of the present study 
was to characterize the structural demands for 
potency and selectivity among hexahydro-sila-di-
fenidol analogues modified in the cyclic amino 
group and in the phenyl ring system. Conse-
quently, the antagonist affinities of compounds 
~-§, 7a and 7b (fig. 2) were determined and com-
pared with those obtained for the parent com-
pound hexahydro-sila-difenidol (!) and the refer-
ence drugs pirenzepine and methoctramine. The 
receptors studied were M1-receptors in rabbit vas 
deferens (Eltze, 1988; Eltze et al., 1988), cardiac 
M2-receptors in guinea-pig atria and smooth 
muscle M 3-receptors in guinea-pig ileum. Further-
more, we report on in vitro experiments with 
hexahydro-sila-difenidol and its p-fluoro deriva-
tive 7b in ganglionic (M1 ), atrial (M 2 ) and ileal 
(M3fpreparations of the rat. 
The agonist independence of the antagonism 
was investigated to verify the mechanism of action 
of p-fluoro-hexahydro-sila-difenidol (7b) (Lam-
brecht et al., 1988a). In addition, antagonist com-
bination experiments were carried out and 
analyzed according to the dose-ratio method of 
Paton and Rang (1965). The results are discussed 
in terms of their implications for musearlnie re-
ceptor classification. 
2. Materials and methods 
2.1. Rabbit isolated vas deferens 
Experiments on rabbit isolated vas deferens 
were performed as described by Eltze (1988). 
Male New Zealand white rabbits were killed by 
i.v. injection of pentobarbital sodium (120 mgjkg). 
Vasa deferentia were removed and segments of 1.5 
cm length were suspended in 7 ml organ baths 
containing modified Krebs buffer (composition in 
mM: NaC1118.0, KC14.7, CaC1 2 2.5, MgS04 0.6, 
KH 2P04 1.2, NaHC03 25.0, ( + )-glucose 11.1; 
10- 6 M yohimbine was included to block a 2-
adrenoceptors) gassed with 95% 02-5% co2 at 
31° C. A resting tension of 0.75 g was applied and 
isometric twitch contractions were elicited by elec-
trical field stimulation (0.05 Hz, 0.5 ms, 30 V). 
These effects were concentration dependently in-
hibited by the M1-selective agonist, 4-(4-chloro-
phenylcarbamoyloxy)-2-butynyltrimethylammoni-
um iodide (4-Cl-McN-A-343) (Eltze et al., 1988) 
and recorded as with the atria. 
2.2. Isolated atria and ileum of the guinea-pig and 
rat 
Adult guinea-pigs and Wistar rats of either sex 
were killed by a blow to the head. Left atria and 
ileum were set up under 0.5 g tension in 6 ml 
organ baths containing oxygenated (95% 0 2-5% 
C02) Tyrode solution (32 o C; composition in mM: 
NaCl 137.0, KCI 2.7, CaC1 2 1.8, MgC1 2 1.05, 
NaHC03 11.9, NaH 2 P04 0.42, ( + )-glucose 5.6). 
The atria were paced at 2 Hz, with bipolar 
platinum electrodes, square-wave pulses of thresh-
old (+50%) valtage and 3 ms pulse width. Nega-
tive inotropic responses to the cumulative addition 
of the muscarinic agonist, arecaidine propargyl 
ester (Mutschler and Hultzsch, 1973; Moseret al., 
1989) were measured as changes in isometric ten-
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sion. A force-displacement transducer connected 
to a Heilige amplifier and a multichannel recorder 
were used for these measurements. Strips of ileal 
longitudinal muscle (1.5 cm length) were prepared 
according to Paton and Zar (1968). The tissue 
responses to the cumulative addition of arecaidine 
propargyl ester were measured as isotonic contrac-
tions and recorded as wi th the atria. 
2. 3. Jsolated superior cervical ganglion of the rat 
Experiments on ganglia were performed as de-
scribed by Brown et al. (1980). Superior cervical 
ganglia were excised from male Sprague-Dawley 
rats (200-300 g) that had been anaesthetized with 
urethane (1.2 gjkg i.p.). Each ganglion was de-
sheathed, suspended vertically in a separate heated 
chamber (36 ° C) and superfused with oxygenated 
(95% 0 2-5% C02 ) Krebs solution (1 mljmin) 
which consisted of (mM): NaCl 124.0, KCI 3.0, 
NaHC03 26.0, NaH 2 P04 1.25, CaC1 2 2.0, MgC1 2 
2.0 and ( + )-glucose 10.0. The muscarine-induced 
depolarization (EC50 = 40 nM) was recorded dif-
ferentially, via two calomel electrodes, between 
the ganglion and its postganglionic trunk. The DC 
potentials were amplified by microvoltmeters 
(Keithley 177) and were monitared on a chart 
recorder. Concentration-response curves were 
made with single doses of muscarine applied at 
20-45 min intervals, followed by a washaut phase 
until the baseline was reached. 
2.4. Antagonist affinities 
The tissues were allowed to equilibrate for 30-60 
min. Concentration-response curves to the agonists 
were obtained before and after adding an antago-
nist. EC50 values were determined for the control 
and the antagonist-shifted concentration-response 
curves. Unless indicated otherwise (table 1), at 
least three concentrations (log interval = 0.48) of 
antagonists were tested in the three tissues, allow-
ing 15-60 min equilibration time. Each concentra-
tion of antagonist was tested 3-5 times and the 
ratios of agonist molar EC50 values obtained in the 
absence and presence of antagonists were calcu-
lated. Schild plots were made, using linear regres-
sion, by the method of least squares. The slopes of 
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these plots were not significantly (P > 0.05) differ-
ent from unity. The pA 2 values were thus esti-
mated by fitting the best straight line with a slope 
equal to unity (Tallarida et al., 1979). 
2.5. Antagonist combination experiments 
The effects of p-fluoro-hexahydro-sila-difenidol 
(7b) in combination with pirenzepine in rabbit vas 
deferens or hexahydro-sila-difenidol (!) in guinea-
pig atria and ileum were investigated on the basis 
of dose ratio analysis (Paton andRang, 1965). The 
concentration-response curves to the agonists in 
these experiments were made under control eondi-
tions then in the presenee of pirenzepine (SO nM), 
hexahydro-sila-difenidol (atria: 3 ~tM; ileum: 100 
nM) or p-fluoro-hexahydro-sila-difenidol (vas de-
ferens: 1 p.M; atria: 3 J.LM; ileum: 100 nM) alone 
or with the respeetive two antagonists eombined. 
The eontaet time for antagonists was always 30 
min and the agonists used were 4-Cl-MeN-A-343 
(vas deferens) and areeaidine propargyl ester (atria 
and ileum), respeetively. The experimental data 
for individual antagonist applications were used to 
ealculate dose ratios (DR) expected for the eombi-
nation for two models: expeeted single-site = DR1 
+ DR 2 - 1 and expeeted independent sites = DR1 
X DR2• Thesedose ratios were eompared with the 
experimentally observed combined mean dose 
ratios. 
2. 6. Statistics 
The data are presented as means ± S.E.M. of 
8-18 experiments with eaeh preparation. The dif-
ferenees between mean values were tested for stat-
istieal signifieanee (P < 0.05) by means of Stu-
dent's t-test. 
2.7. Drugs 
Carbaehol (earbamylcholine ehloride), d,l-
musearine ehloride and yohimbine hydroehloride 
(Sigma); oxotremorine sesquifumarate (Ega-Che-
mie); pirenzepine dihydrochloride (Boehringer In-
gelheim); methoetramine tetrahydroehloride 
(kindly provided by Dr C. Melchiorre, University 
of Bologna, ltaly); MeN-A-343 (4-(3-ehlorophen-
ylcarbamoyloxy)-2-butynyltrimethylammonium 
ehloride) (Serva); areeaidine propargyl ester 
(Mutschler and Hultzseh, 1973), 4-Cl-McN-A-343 
(4-(4-ehlorophenylcarbamoyloxy)-2-butynyltri-
methylammonium iodide) (Nelson et al., 1976) as 
well as compounds ! -§, 7 a and 7b were syn the-
sized in our laboratories (Tacke et al., 1985: !; 
silicon eompounds f-Q and 7b were prepared by 
analogy to the synthesis of theparent eompound! 
and the earbon eompound 7a was prepared by 
analogy to the synthesis of hexahydro-difenidol; 
unpublished results). The other chemieals were of 
reagent grade and were used as purchased. 
Compounds !-.§, 7a and 7b possess a eentre of 
ehirality and therefore exist1n two enantiomers. 
They were used as racemates because indications 
were found that the enantiomers of silanals of this 
type may raeemize in aqueous solution (Tacke et 
al., 1987). 
3. Results 
The inhibition of twitch eontraction indueed by 
4-Cl-MeN-A-343 (EC50 = 250 nM) in field-stimu-
lated rabbit vas deferens and the muscarine-in-
dueed depolarization in rat ganglia as weil as the 
arecaidine propargyl ester-mediated responses in 
atria and ileum of guinea-pigs and rats were 
antagonized by eompounds !-§, 7a and 7b. The 
antagonists produced coneentration-dependent 
parallel shifts of the agonist eoncentration-re-
sponse eurves without either basal tension or max-
imum response being affected at the concentration 
range tested. The Schild plots were linear and the 
slopes were not significantly different from unity 
(P > 0.05). Thus, all compounds were apparently 
simple competitive muscarinie antagonists. These 
resul ts are summarized in tables 1 and 2. 
3.1. Antagonist affinities in rabbit vas deferens and 
guinea-pig atria and ileum 
Compounds !-§, 7a and 7b showed quite wide 
variations in their affinities To the musearlnie re-
eeptors in vas deferens, atria and ileum, their pA 2 
values (table 1) differing by more than two orders 
of magnitude. As with the parent eompound, 
hexahydro-sila-difenidol (!), the derivatives ~-§ 
and 7a exhibited similar affinities at reeeptors 
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TABLE 1 
Affinity profiles of pirenzepine, methoctramine and compounds !-~. 7a and 7b at muscarinic M1-receptors in rabbit vas deferens 
(RVD) and at M 2-receptors in guinea-pig atria (GPA) as well as at M 3-receptorsin guinea-pig ileum (GPI). pA 2 values and slopes of 
Schild plots (in parentheses) were calculated as described in Methods (antagonist affinities) and are presented as means ± S.E.M. The 
ratios of affinity constants are given as a measure of receptor selectivity. These values were calculated from the antilogs of the 
differences between respective pA 2 values. 
pA2 Selectivity ratios 
RVD-M 1 GPA-M 2 GPI-M 3 Ml/Mz M 3 jM1 M3/Mz 
Pirenzepine a 8.24±0.06 6.82±0.03 6.88±0.04 26 0.04 1.2 
(1.19±0.10) (0.98 ± 0.02) (1.07 ± 0.04) 
Methoctramine 6.85±0.07 a 7.69±0.03 6.17 ±0.05 0.15 0.21 0.03 
(1.19 ± 0.10) (1.05 ± 0.05)· (0.99 ± 0.09) 
1 a,b 7.92±0.07 6.53 ±0.05 7.96±0.03 25 1.1 27 
( 1.09 ± 0.03) (0.96±0.09) (0.93 ± 0.06) 
2 7.78±0.09 d 6.73±0.04 8.13 ±0.05 11 2.2 25 
(1.07 ± 0.04) (0.96 ± 0.04) (0.88 ± 0.08) 
J 7.13 ±0.10 d 5.92±0.04 c 7.48 ±0.02 16 2.2 36 
(1.23 ± 0.07) (1.06 ± 0.05) 
4 6.77±0.10 d 5.79±0.06 c 6.74±0.05 9.5 0.93 8.9 
(1.21 ± 0.06) (0.99±0.11) 
~ 6.74±0.08 d 5.59±0.03 c 7.09±0.06 14 2.2 32 
(1.06 ± 0.04) (0.94±0.12) 
6 6.82±0.07 5.50±0.05 c 7.06±0.03 21 1.7 36 
(1.08±0.21) (0.93 ± 0.07) 
7a 7.56±0.07 6.58±0.03 7.93 ±0.03 9.5 2.3 22 
(0.95 ± 0.16) (1.05 ± 0.08) (0.89 ± 0.04) 
7b a 6.68±0.03 e 6.01 ±0.06 c 7.84±0.03 r 4.7 15 68 
(1.12±0.21) (1.08 ± 0.06) 
a Data taken from Eltze and Figala (1988) and Lambrecht et al. (1988a). b Hexahydro-sila-difenidol. c Only one or two concentra-
tions of the antagonists were investigated due to the negative inotropic effects of the antagonists themselves at higher concentrations: 
J (11'M), ~ (31'M), ~ (3 and 10 I'M), ~ (1 MM), 7b (1 and 31'M). The pA 2 values were therefore determined from the individual dose 
ratios according to Tallarida et al. (1979). d pA~values and slopes of Schildplotstaken from Eltze et al. (1988). e A pA 2 value of 
6. 95 ± 0.04 was obtained using McN -A-343 as agonist. r pA 2 values of 7.83 ± 0.08 and 7.89 ± 0.07 were obtained using carbachol and 
oxotremorine, respectively. as agonists. 
TABLE 2 
The affinities of hexahydro-sila-difenidol (!) and p-fluoro-hexahydro-sila-difenidol (7b) for muscarinic M1-receptors in rat superior 
cervical ganglia (RG), M 2-receptors in rat atria (RA) and M 3-receptors in rat ileum (RI). pA 2 values and slopes of Schild plots (in 
parentheses) are presented as means ± S.E.M. The ratios of aHinity constants are given as a measure of receptor selectivity. These 
values were calculated from the antilogs of the differences between respective pA 2 values. 
pAz Selectivity ratios 
RG-M1 a RA-M 2 RI-M 3 MI/Mz M3/M1 M 3 jM 2 
! 7.54±0.07 6.22±0.05 7.77±0.06 21 1.7 36 
(0.98 ± 0.04) (1.20±0.11) (1.00±0.11) 
7b 7.21±0.04 5.99±0.04 7.88±0.02 16 4.7 78 
(1.04±0.06) (0.91 ±0.10) (0.98±0.05) 
• The pA 2 value observed in this preparation for pirenzepine was 8.30 (Lambrecht et al., 1988c). 
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Fig. 3. Comparison of the affinities {pA 2; table 1) of pirenzepine (Pz), methoctramine (Me) and compounds !-~. 7a and 7b at 
muscarinic M1-receptors in rabbit vas deferens (panels band c), Mrreceptors in guinea-pig atria (panels a and c) andM 3-receptors 
in guinea-pig ileum (panels a and b). If the affinities are not the same for two receptors, the results deviate from the theoretical 
equality line (y ... x), and the distance from this line is then a measure of receptor selectivity. The dotted lines represent the following 
receptor selectivity ratios, panel a: M3 (ileum)/M 2 (atria) = 25; panel b: M 3 (ileum)/M1 (vas deferens) .... 2.2; panel c: M1 (vas 
deferens)/M 2 (atria) = 15. 
present in the vas deferens and ileum (dotted line 
in fig. 3, panel b), but the pA 2 values obtained in 
atria were much lower. This selectivity profile of 
the compounds is demonstrated by the selectivity 
ratios given in table 1 and is illustrated in fig. 3. 
A different selectivity pattem was observed for 
p-fluoro-hexahydro-sila-difenidol (7b ). This anti-
muscarinic agent exhibited the highest affinity 
(pA 2 = 7.84) for the receptors in the ileum, an 
intermediate affinity for the receptors in vas de-
ferens (pA 2 = 6.68) and lowest affinity for the 
cardiac receptors (pA 2 = 6.01 ). 
3.2. Antagonist affinities in rat ganglia, atria and 
ileum 
Hexahydro-sila-difenidol (!) and i ts p-fluoro 
derivative 7b were tested in three isolated prepara-
tions of the rat: superior cervical ganglia (M1 ), 
atria (M 2) and ileallongitudinal muscle (M3). The 
pA 2 values and corresponding Schild slopes are 
shown in table 2. Although there were some 
quantitative differences, both compounds showed 
qualitatively the same receptor selectivity profile 
as was found in rabbit vas deferens and guinea-pig 
atria and ileum ( table 1 ); hexahydro-sila-difen-
idol: MI = M3 > M 2 , p-fluoro-hexahydro-sila-dif-
enidol: M3 > MI > M 2 • 
3. 3. Combination experiments 
The mutual competition between p-fluoro-
hexahydro-sila-difenidol (7b) and pirenzepine or 
TABLE 3 
Summary of dose ratio analysis from the P""fluoro-he'lahydro-
sila-difenidol (7b) combination e'lperiments. Each dose ratio 
(DR) is the mean± S.E.M. and the number of observations is 
given in parentheses. 
Rabbit vas deferens (M1) 
Pirenzepine (50 nM) 
Compound 7b (1 ,uM) 
Expected single site DR a 
Experimental combination DR 
E.Jcpected independent site DR b 
Guinea·pig atria (M1) 
Compound! c (3 ,uM) 
Compound 7b (3 ,uM) 
E.Jcpected single site DR • 
&perimental combination DR 
&pected independent site DR b 
Guinea-pig ileum (M3 ) 
Compound ! c (100 nM) 
Compound 7b (100 nM) 
Expected single site DR • 
Experimental combination DR 
Expected independent site DR b 
Mean dose ratio 
6.8 ±0.8 (n = 5) 
15±2.3 (n = 5) 
20.8 
27 ± 2.5 (n == 5) 
102 
12± 1.2 (n == 6) 
3.9±0.1 (n == 6) 
14.9 
18±4.5(n=6) 
47 
16± 2.2 (n = 8) 
8.7 ± 0.8 (n = 8) 
23.7 
20± 2.7 (n- 8) 
139 
• DR1 + DR 2 -1. b DR1 x DR 2 • c Hexahydro-sila-difenidol. 
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the parent compound! was investigated in rabbit 
vas deferens and guinea-pig atria and ileum, re-
spectively, on the basis of dose ratio analysis 
(Paton and Rang, 1965). The results of these ex-
periments are summarized in table 3. The com-
bined dose ratios obtained experimentally in the 
three preparations were very close to those calcu-
lated for two antagonists acting at a single site. 
The results are not consistent (P < 0.05) with a 
multiplication of dose ratios which would be ex-
pected if two antagonists interacted at indepen-
dent sites. 
4. Discussion 
4.1. General considerations 
The presynaptic musearlnie receptors in rabbit 
vas deferens and the postsynaptic receptors in 
guinea-pig atria and ileum have been weil estab-
lished tobelang to different subclasses: ganglionic 
M1-, cardiac M 2- and smooth musclejglandular 
M3-receptors (Eltze, 1988; Eltze and Figala, 1988; 
Eltze et al., 1988; Lambrecht et al., 1988a-c; 1989). 
This heterogeneity is based mainly on the differ-
ent affinities of selective antagonists such as 
pirenzepine (M1 > M 2 = M 3), methoctramine (M 2 
> M1 > M3 ) and hexahydro-sila-difenidol (!; MI 
= M3 > M2 ) (table 1). 
The present study concemed the effects of 
changing the size of the cyclic amino group ( com-
pounds ~ and ~) and introducing substituents in 
the phenyl ring ( compounds ~-Q, 7b) of hexahy-
dro-sila-difenidol (1) as weil as offeplacing the 
central silicon atom of compound 7b by a carbon 
atom (compound 7a) on muscarinicpotency. 
The principal conclusions drawn from these 
experiments are that: (1) compounds !-Q, 7a and 7b 
act as competitive musearlnie antagonists in rabbit 
vas deferens as weil as in guinea-pig atria and 
ileum. They produced an antagonism that was 
reversible and surmountable and their apparent 
affinity in each tissue appeared tobe independent 
of the concentrations used. Thus, Schild analysis 
yielded slopes which were not significantly differ-
ent from unity (table 1). The affinity constants of 
p-fluoro-hexahydro-sila-difenidol (7b) in rabbit 
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vas deferens and guinea-pig ileum were indepen-
dent of. the agonist used (rabbit vas deferens: 
McN-A-343 = 6.95; 4-Cl-McN-A-343 = 6.68; 
guinea-pig ileum: arecaidine propargyl ester = 
7.84; carbachol = 7.83; oxotremorine = 7.89) (ta-
ble 1). In addition to the data obtained from the 
Schild analysis, combination sturlies (table 3) 
showed compound 7b to act in a manner indis-
tinguishable from 'classical' competitive antago-
nists. (2) Structural variations in the hexahydro-
sila-difenidol molecule led to new musearlnie 
antagonists which exhibit a qualitatively andjor 
quantitatively different spectrum of receptor selec-
tivity to the parent compound. The selectivity 
observed does not appear to be associated with 
high affinity as there are less potent compounds 
with appreeiable selectivity (compounds ~-§; table 
1 and fig. 3). 
4.2. Structure-selectivity re/ationships 
The influence of the ring size of the cyclic 
amino group on potency and seleetivity ean be 
demonstrated by eomparison of eompounds !-~. 
As can be seen from the data in table 1 the 
affinity to the three musearlnie reeeptor subtypes 
depends on the nature of the heterocyclie ring 
system and varies up to about 6-fold. Compound 
~' eontaining a pyrrolidino ring, shows nearly the 
same affinity to MI-, M 2- and M 3-reeeptors as the 
parent compound, hexahydro-sila-difenidol (!). In 
contrast, ring extension to the hexamethyleneimino 
derivative ~ results in a deerease in affinity for all 
subtypes. However, the influence of the size of the 
cyclic amino group on seleetivity is moderate as 
compounds ~ and ~ showed the same selectivity 
pattern as the parent compound !: MI=::: M 3 > M 2 • 
Therefore eompounds !-l deviate significantly 
from the line of equivalence when the pA 2 values 
in guinea-pig atria are compared to those in the 
ileum and rabbit vas deferens, respectively (fig. 3, 
panels a and c). 
Comparison of compounds !, ~§ and 7b de-
fines the effect of substituents in the phenYJ ring 
of hexahydro-sila-difenidol. Either a methoxy sub-
stituent in the ortho or para position ( compounds 
~ and ,2) or a para-chloro substituent (compound 
§) reduces the affinity to the musearlnie receptors 
up to more than one order of magnitude (table 1). 
Thus, compounds ~-§ were even less potent than 
the hexamethyleneimino derivative 1. On the other 
hand, compounds ~-§ retain the same selectivity 
profile as the parent compound ! and the deriva-
tives ~ and ~: MI :::::: M3 > M 2 (table 1 and fig. 3}. 
A novel affinity profile was observed for p-
fluoro-hexahydro-sila-difenidol (7b): M 3 > M1 > 
M 2 • This compound exhibited high affinity for 
smooth muscle M 3-receptors in guinea-pig ileum 
(pA 2 = 7.84) while its antimusearinie poteney at 
MI-receptors in rabbit vas deferens and eardiac 
M 2-receptors in guinea-pig atria was lower by 
factors of 15 and 68, respeetively (table 1, fig. 3}. 
This novel selectivity profile of 7b is based on the 
fact that the para-fluoro substituent Ieads to a 
decrease in Mc and M 2-antimuscarinic potency 
while only slightly affecting the affinity towards 
Mrreceptors. 
The pA 2 values determined for p-fluoro-hexa-
hydro-sila-difenidol (7b) in rat atria and ileum 
(5.99 and 7.88, respectively; table 2) were very 
close to that found in the corresponding guinea-pig 
tissues (6.01 and 7.84, respectively; table 1). The 
pA 2 value observed for compound 7b at M1-re-
ceptors in rat superior cervical ganglia(7.21 using 
muscarine as agonist; table 3) was slightly higher 
than that found in rabbit vas deferens (6.68 using 
4-Cl-MeN-A-343 and 6.95 using McN-A-343 as 
agonists; table 1). However, the data obtained 
with the three rat tissues show that the reeeptor 
seleetivity profile of p-fluoro-hexahydro-sila-difen-
idol (M 3 > M 1 > M 2 ) is speeies-independent. This 
also holds for the parent compound, hexahydro-
sila-difenidol (M1 :::::: M3 > M 2; tables 1 and 2). 
Replacement of the central silicon atom in 
eompound 7b by a earbon atom (7b---+ 7a) in-
ereased the affinity for M 1-receptors in rabbit vas 
deferens as well as for cardiae M 2-receptors in 
guinea-pig atria by factors of 8 and 4, respectively, 
whereas the affinity to M 3-receptors in guinea-pig 
ileumwas not changed significantly (P > 0.05) (ta-
ble 1). Thus, the seleetivity profile of p-fluoro-
hexahydro-difenidol (7a) is similar to that of the 
silicon compounds !-§ (fig. 3), but differs from 
that of its sila analogue 7b). This is a further 
example indicating that sila substitution (C/Si 
exchange) may be a useful tool to improve recep-
tor selectivity (for a recent review on CjSi-bioiso-
sterism, see Tacke and Linoh, 1989). 
In conclusion this report describes structure-ac-
tivity relationships of antimuscarinics related to 
hexahydro-sila-difenidol (!). The antimuscarinic 
potency and selectivity in this series of compounds 
(!-Q, 7a and 7b; fig. 2) is controlled by the Sub-
stitution pattem of the phenyl moiety, the struc-
ture of the cyclic amino group and the nature of 
the central atom 'EI' (carbon or silicon). Com-
pounds with qualitatively andjor quantitatively 
different receptor selectivity profiles were ob-
tained. Among the antimuscarinic agents tested in 
this study, p-fluoro-hexahydro-sila-difenidol (7b) 
is the only compound which showed appreciable 
M 3-receptor selectivity (M 3 > M 1 > M 2 ). Its affin-
ity profile is different from that of the parent 
compound, hexahydro-sila-difenidol (!) (M1 == M 3 
> M 2 ), and its selectivity for Mrreceptors is com-
parable to that of pirenzepine for M 1- and 
methoctramine for M 2-receptors (fig. 3). p-
Fluoro-hexahydro-sila-difenidol (7b) therefore 
represents a useful tool for the subclassification of 
muscarinic receptors. 
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